Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery

Phase 3

Active, not recruiting

Conditions: Spinal Surgery

Interventions: Drug: Methadone

First Posted Date: 2022-06-14

Last Posted Date: 2025-01-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT05417100

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2022-06-14

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 88

Registration Number: NCT05416996

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1

Recruiting

Conditions: Breast Cancer
Invasive Breast Cancer

Interventions: Diagnostic Test: Pre-neoadjuvant radiotherapy (NART) biopsy
Radiation: Neoadjuvant radiotherapy
Procedure: Unilateral total mastectomy with axillary lymph node dissection

First Posted Date: 2022-06-09

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 60

Registration Number: NCT05412225

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 4 locations

Collecting Dietary Information From People Undergoing Cancer Treatment

Active, not recruiting

Conditions: Receiving Allogeneic Hematopoietic Cell Transplants

First Posted Date: 2022-06-03

Last Posted Date: 2025-05-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT05404009

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Phase 2

Recruiting

Conditions: Multiple Myeloma

Interventions: Biological: Ide-cel (bb2121)

First Posted Date: 2022-05-26

Last Posted Date: 2025-02-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 32

Registration Number: NCT05393804

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

Recruiting

Conditions: Solid Tumor

First Posted Date: 2022-05-25

Last Posted Date: 2024-11-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3644

Registration Number: NCT05390827

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Mosunetuzumab in People With Follicular Lymphoma

Phase 2

Recruiting

Conditions: Follicular Lymphoma
Lymphoma

Interventions: Drug: Mosunetuzumab
Drug: Zanubrutinib

First Posted Date: 2022-05-25

Last Posted Date: 2025-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 76

Registration Number: NCT05389293

Locations: 🇺🇸
Georgetown University (Data Collection Only), Washington, District of Columbia, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge, New Jersey, United States
🇺🇸
Hackensack Meridian Health (Data collection only), Hackensack, New Jersey, United States

and more 6 locations

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Early Phase 1

Active, not recruiting

Conditions: Acute Lymphoblastic Leukemia

Interventions: Drug: Venetoclax

First Posted Date: 2022-05-23

Last Posted Date: 2024-06-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT05386576

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

Phase 2

Recruiting

Conditions: Mucosal Melanoma

Interventions: Drug: Nivolumab and/or Ipilimumab
Radiation: Stereotactic Body Radiation Therapy (SBRT)
Drug: axitinib

First Posted Date: 2022-05-20

Last Posted Date: 2025-02-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT05384496

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Iberdomide

First Posted Date: 2022-04-29

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT05354557

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Followup), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent and Follow-Up only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale, New Jersey, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy